Sitagliptin and shock wave-supported peripheral blood derived endothelial progenitor cell therapy effectively preserves residual renal function in chronic kidney disease in rat—role of dipeptidyl peptidase 4 inhibition
In conclusion Sita associated SW-assisted EPC effectively protected residual renal function in CKD.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Kidney Disease | Diets | Drugs & Pharmacology | Januvia | Nephrectomy | Nutrition | Proteinuria | Study | Ultrasound | Urology & Nephrology